A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
NCT00002160 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2005-06-24
Summary
To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.
Conditions
Interventions
- DRUG
-
Ziconotide
Sponsors & Collaborators
-
Neurex
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Neuropathic Pain in Patients With Cancer
NCT00474916 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
NCT03773055 ·Status: TERMINATED ·Phase: PHASE2
-
Ziconotide for Non-cancer Pain by Intrathecal Administration
NCT06541184 ·Status: RECRUITING
-
Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
NCT00050271 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain
NCT05359133 ·Status: TERMINATED ·Phase: PHASE2
-
A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
NCT01195636 ·Status: COMPLETED ·Phase: PHASE2
-
A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain
NCT05661734 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
NCT07122453 ·Status: RECRUITING ·Phase: PHASE1
-
Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy
NCT01992562 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01088256 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Tanezumab in Adults With Chronic Low Back Pain
NCT00876187 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)
NCT00233155 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
NCT00576277 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
[S,S]-Reboxetine Dose-Range Finding Trial
NCT00288652 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Transfer for Cancer Pain
NCT00804076 ·Status: COMPLETED ·Phase: PHASE1
-
AZD2066 Neuropathic Pain - Mechanical Hypersensitivity
NCT00939094 ·Status: TERMINATED ·Phase: PHASE2
-
Injection Therapy for Neuropathic Pain
NCT05809700 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain
NCT01920087 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects
NCT03787004 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients
NCT00286377 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain
NCT01264237 ·Status: UNKNOWN ·Phase: PHASE4
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
NCT00625833 ·Status: TERMINATED ·Phase: PHASE2
-
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00489411 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)
NCT00592774 ·Status: COMPLETED ·Phase: PHASE2